| |
| Issue |
Title |
| |
| No 19 (2019) |
Sensitivity of patients to the disease depending on the degree of its awareness in breast cancer |
Abstract
PDF (Rus)
|
|
L. M. Kogoniya, A. S. Nelyubina, E. V. Markarova, E. E. Tuntsova |
| |
| No 19 (2019) |
Results of using 3-component regimen TEGOXIRI (tegafur, oxaliplatin, irinotecan) ± Leucovorin in patients with advanced colorectal cancer |
Abstract
PDF (Rus)
|
|
N. V. Dobrova, A. D. Darenskaya |
| |
| No 19 (2019) |
Tolerance of ramucirumab in the second-line therapy of patients with disseminated gastric cancer in the routine clinical practice of Russia |
Abstract
PDF (Rus)
|
|
N. S. Besova, T. A. Titova, E. V. Artamonova, D. L. Stroyakovskiy, E. V. Perminova, D. Yu. Yukal’chuk, D. M. Ponomarenko, N. P. Belyak, R. V. Orlova, G. M. Teletaeva, E. Yu. Ratner, A. S. Mochalova, O. O. Gordeeva, A. S. Zhabina, S. V. Gamayunov, A. V. Smolin, A. Yu. Povyshev, M. I. Andrievskikh, A. A. Tryakin, I. S. Stilidi |
| |
| No 10 (2019) |
Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer |
Abstract
PDF (Rus)
|
|
N. S. Besova, T. A. Titova, D. L. Stroyakovsky, E. V. Perminova, S. G. Bagrova, E. S. Obarevich, V. A. Gorbunova, E. V. Artamonova, I. S. Stilidi |
| |
| No 10 (2019) |
A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation |
Abstract
PDF (Rus)
|
|
K. K. Laktionov, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov, D. T. Marinov, D. A. Peregudov, M. S. Ardzinba |
| |
| No 10 (2019) |
Potential for use sunitinib in pancreatic neuroendocrine tumors |
Abstract
PDF (Rus)
|
|
A. A. Markovich, A. A. Kuznetsova, V. A. Gorbunova, N. F. Orel, A. S. Odintsova, G. S. Emelyanova, A. E. Kuzminov |
| |
| No 10 (2019) |
Results of the use of trastuzumab combined with different chemotherapy regimens in first-line treatment of HER2-positive disseminated gastric cancer |
Abstract
PDF (Rus)
|
|
N. S. Besova, T. A. Titova, S. G. Bagrova, E. S. Obarevich, V. A. Gorbunova, E. V. Artamonova |
| |
| No 19 (2018) |
Intermediate results of combination therapy in patients with oligometastatic non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
D. I. Yudin, K. K. Laktionov, D. T. Marinov, V. V. Breder, A. K. Allakhverdiev, T. N. Borisova, A. H. Bekyashev, K. P. Laktionov, V. A. Aleshin, M. S. Ardzinba |
| |
| No 19 (2018) |
Characteristics of population of patients with sarcoidiosis in the republic of Tatarstan: the results of multi-year monitoring |
Abstract
PDF (Rus)
|
|
I. Yu. Vizel, A. A. Vizel, G. R. Shakirova, G. S. Ganibaeva |
| |
| No 10 (2018) |
Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment |
Abstract
PDF (Rus)
|
|
V. O. Bashlyk, A. G. Kudaibergenova, A. S. Artemyeva, A. L. Muravtseva, V. S. Chirsky, T. Yu. Semiglazova, V. V. Klimenko, V. F. Semiglazov |
| |
| No 14 (2017) |
BREAST CANCER IN MEN IN THE REPUBLIC OF BASHKORTOSTAN |
Abstract
PDF (Rus)
|
|
D. D. Sakaeva, R. D. Atnabaev, V. V. Ruchkin |
| |
| No 6 (2017) |
INFLUENCE OF THE RECOMBINANT TUMOR NECROSIS FACTOR THYMOSIN-α1 ON ANGIOGENESIS IN DISSEMINATED SKIN MELANOMA PATIENTS |
Abstract
PDF (Rus)
|
|
I. A. KOROLEVA, E. G. SLAVINA, A. I. CHERTKOVA, V. A. NURTDINOVA, E. K. SHOUA, M. E. ABRAMOV, Z. G. KADAGIDZE |
| |
| 1 - 12 of 12 Items |
|
